Search Login Register

N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine Summary

Description: structure given in first source; a selective A(3) adenosine receptor agonist

Also Known As: 3-IB-MECA; IB-MECA; N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide; N(6)-IBAMU

Networked: 64 relevant articles (13 outcomes, 12 trials/studies) for this Bio-Agent

Key Diseases for which N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine is Relevant

  1. Ischemia : 4 outcomes in 10 results
  2. Infarction : 2 outcomes 1 study in 4 results
  3. Myocardial Stunning (Stunned Myocardium) : 2 outcomes 1 study in 3 results
  4. Lung Injury : 2 outcomes in 3 results
  5. Necrosis : 2 outcomes in 3 results
Show All >>

Drugs Related to N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine

  1. Adenosine A3 Receptor
  2. Adenosine A1 Receptor
  3. Purinergic P1 Receptors (Adenosine Receptor)
  4. MRS 1191
  5. Staphylococcal Protein A (A, Protein)
  6. Phosphotransferases (Kinase)
  7. 1,4-dihydropyridine (dihydropyridine)
  8. Adenosine
  9. 2- chloro- N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosine (Cl-IB-MECA)
  10. purine
Show All >>

Therapies Related to N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine

  1. Drug Therapy (Chemotherapy)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.